205 related articles for article (PubMed ID: 28943105)
1. A549 cells as a model to study endogenous LPA
Carmona-Rosas G; Alfonzo-Méndez MA; Hernández-Espinosa DA; Romero-Ávila MT; García-Sáinz JA
Eur J Pharmacol; 2017 Nov; 815():258-265. PubMed ID: 28943105
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
Olianas MC; Dedoni S; Onali P
Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA1, LPA2, and LPA3.
Alcántara-Hernández R; Hernández-Méndez A; Campos-Martínez GA; Meizoso-Huesca A; García-Sáinz JA
PLoS One; 2015; 10(10):e0140583. PubMed ID: 26473723
[TBL] [Abstract][Full Text] [Related]
4. LPA1 Mediates Antidepressant-Induced ERK1/2 Signaling and Protection from Oxidative Stress in Glial Cells.
Olianas MC; Dedoni S; Onali P
J Pharmacol Exp Ther; 2016 Nov; 359(2):340-353. PubMed ID: 27605627
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation and desensitization of the lysophosphatidic acid receptor LPA1.
Avendaño-Vázquez SE; García-Caballero A; García-Sáinz JA
Biochem J; 2005 Feb; 385(Pt 3):677-84. PubMed ID: 15369458
[TBL] [Abstract][Full Text] [Related]
6. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
Chen M; Towers LN; O'Connor KL
Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
[TBL] [Abstract][Full Text] [Related]
7. LPA receptor1 antagonists as anticancer agents suppress human lung tumours.
Zhao PF; Wu S; Li Y; Bao G; Pei JY; Wang YW; Ma Q; Sun HJ; Damirin A
Eur J Pharmacol; 2020 Feb; 868():172886. PubMed ID: 31866407
[TBL] [Abstract][Full Text] [Related]
8. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid stimulates prostaglandin E2 production in cultured stromal endometrial cells through LPA1 receptor.
Woclawek-Potocka I; Kondraciuk K; Skarzynski DJ
Exp Biol Med (Maywood); 2009 Aug; 234(8):986-93. PubMed ID: 19491366
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine increases glial cell line-derived neurotrophic factor production through lysophosphatidic acid 1 receptor-mediated extracellular signal-regulated kinase signaling in astrocytes.
Hisaoka-Nakashima K; Taki S; Watanabe S; Nakamura Y; Nakata Y; Morioka N
Eur J Pharmacol; 2019 Oct; 860():172539. PubMed ID: 31306636
[TBL] [Abstract][Full Text] [Related]
12. Differential targeting of lysophosphatidic acid LPA
Olianas MC; Dedoni S; Onali P
Eur J Pharmacol; 2023 Nov; 959():176064. PubMed ID: 37758013
[TBL] [Abstract][Full Text] [Related]
13. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.
David M; Ribeiro J; Descotes F; Serre CM; Barbier M; Murone M; Clézardin P; Peyruchaud O
Int J Oncol; 2012 Apr; 40(4):1133-41. PubMed ID: 22200658
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid signaling through LPA receptor subtype 1 induces colony scattering of gastrointestinal cancer cells.
Shin KJ; Kim YL; Lee S; Kim DK; Ahn C; Chung J; Seong JY; Hwang JI
J Cancer Res Clin Oncol; 2009 Jan; 135(1):45-52. PubMed ID: 18592268
[TBL] [Abstract][Full Text] [Related]
16. LPA
Dancs PT; Ruisanchez É; Balogh A; Panta CR; Miklós Z; Nüsing RM; Aoki J; Chun J; Offermanns S; Tigyi G; Benyó Z
FASEB J; 2017 Apr; 31(4):1547-1555. PubMed ID: 28069828
[TBL] [Abstract][Full Text] [Related]
17. RAFTK/Pyk2 mediates LPA-induced PC12 cell migration.
Park SY; Schinkmann KA; Avraham S
Cell Signal; 2006 Jul; 18(7):1063-71. PubMed ID: 16199135
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid (LPA) as a modulator of plasma membrane Ca
Sant'Anna JF; Baldez VS; Razuck-Garrão NA; Lemos T; Diaz BL; Einicker-Lamas M
J Physiol Biochem; 2021 May; 77(2):321-329. PubMed ID: 33704695
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid signals through mitogen-activated protein kinase-extracellular signal regulated kinase in ovarian theca cells expressing the LPA1/edg2-receptor: involvement of a nonclassical pathway?
Budnik LT; Brunswig-Spickenheier B; Mukhopadhyay AK
Mol Endocrinol; 2003 Aug; 17(8):1593-606. PubMed ID: 12730329
[TBL] [Abstract][Full Text] [Related]
20. Participation of analogues of lysophosphatidic acid (LPA): oleoyl-sn-glycero-3-phosphate (L-alpha-LPA) and 1-oleoyl-2-O-methyl-rac-glycerophosphothionate (OMPT) in uterine smooth muscle contractility of the pregnant pigs.
Markiewicz W; Kamińska K; Bogacki M; Maślanka T; Jaroszewski J
Pol J Vet Sci; 2012; 15(4):635-43. PubMed ID: 23390752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
